Cancer drug durvalumab tested in everyday practice
NCT ID NCT04068168
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study checked how safe and effective the cancer drug durvalumab (Imfinzi) is when used in real-world clinics, not just in strict research settings. It included 712 people in Korea with lung or biliary tract cancer who were already eligible for the drug. Researchers tracked side effects and how well the drug controlled the cancer over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Anyang-si, South Korea, South Korea
-
Research Site
Bucheon-si, South Korea, South Korea
-
Research Site
Busan, South Korea, South Korea
-
Research Site
Changwon, South Korea, South Korea
-
Research Site
Changwon-si, South Korea, South Korea
-
Research Site
Cheonan, South Korea, South Korea
-
Research Site
Chuncheon, South Korea, South Korea
-
Research Site
Daegu, South Korea, South Korea
-
Research Site
Daejeon, South Korea, South Korea
-
Research Site
Goyang-si, South Korea, South Korea
-
Research Site
Gwangju, South Korea, South Korea
-
Research Site
Hwasun-gun, South Korea, South Korea
-
Research Site
Iksan-si, South Korea, South Korea
-
Research Site
Incheon, South Korea, South Korea
-
Research Site
Jeju-do, South Korea, South Korea
-
Research Site
Jeonju, South Korea, South Korea
-
Research Site
Pohang-si, South Korea, South Korea
-
Research Site
Seongnam-si, South Korea, South Korea
-
Research Site
Seoul, South Korea, South Korea
-
Research Site
Suwon, South Korea, South Korea
-
Research Site
Uijeongbu-si, South Korea, South Korea
-
Research Site
Wŏnju, South Korea, South Korea
-
Research Site
Yangsan, South Korea, South Korea
-
Research Site
Yongin-si, South Korea, South Korea
Conditions
Explore the condition pages connected to this study.